MK

Matthew Keller

#1652 out of 1697 analysts
HC Wainwright & Co.
Automatically Tracked
Tracking: 0 Updated: Aug 20 at 01:17 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-57.76%
Gain -1.6%
Monthly
-6.81%
Yearly
-57.07%
Drawdown
71.68%
$42,241.79
Equity
Holdings
$27,607.42
Cash
$14,634.37
Investment
$32,098.08
-$57,758.21
Profit -$686.97
Realized
-$53,267.55
Unrealized
-$4,490.66
Dividends
$0
$14,634.37
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-1.6%
Profit
-$686.97
Win %
40%
This Week
Compared To Last Week
Gain
4.86%
Profit
$1,958.21
Win %
40%
This Month
Compared to last month
Gain
4.74%
Profit
$1,910.32
Win %
40%
This Year
Compared to last year
Gain
-24.66%
Profit
-$13,824.2
Win %
31%
Galectin Therapeutics Inc. logo
GALT Galectin Therapeutics Inc.
0%
$0
Seres Therapeutics, Inc. logo
MCRB Seres Therapeutics, Inc.
0%
$0
No Data
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
65
Longs Won
20/65 30%
Profit Factor
0.31
Profitability
Shorts Won
0/0 0%
Standard Deviation
$2,976.53
Average Win
$1,322.4
Best Trade
(Nov 22) $5,083.86
Sharpe Ratio
-129.31
Average Loss
-$1,871.25
Worst Trade
(Mar 27) -$13,138.02
Z-Score
-1.53 (87.92%)
Commissions
$0
Avg. Trade Length
1m 2w 2d
Expectancy
-$888.59
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 23 20 18 16 14 11 9 7 5 2
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit ($) Gain (%) Change
Galectin Therapeutics Inc. logo
GALT Galectin Therapeutics Inc.
3,987.57 $12,441.21 $14,036.23 - $1,595.02 12.82%
0.0
Seres Therapeutics, Inc. logo
MCRB Seres Therapeutics, Inc.
3,127 $19,656.87 $13,571.19 - -$6,085.68 -30.96%
0.0
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV